About: ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 05 October 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2020 (fr) artículu científicu espublizáu n'ochobre de 2020 (ast) scientific article published on 05 October 2020 (en) наукова стаття, опублікована 5 жовтня 2020 (uk)
publication date	wds:Q100444166-DD64EFFC-6608-40E3-92C0-14BE270BD235
publication date	2020-10-05 00:00:00Z (xsd:dateTime)
cites work	wds:Q100444166-04DDE361-7DCA-41E2-BB59-8DD59ACAFBC0 wds:Q100444166-089E1059-731C-4EDB-BF02-3D5A295BAF1A wds:Q100444166-1075FF0A-ACD4-4E91-94AF-AA8A92AA11D6 wds:Q100444166-19D4F5C4-0143-42EC-9095-D02586E9D00B wds:Q100444166-3221CF40-FCD8-4394-BD3F-F24CF96A7408 wds:Q100444166-3AF9FF97-A06C-4C69-8CC9-527765CBBECC wds:Q100444166-3BAF8D6B-18A8-4175-8171-14B0FB512CD9 wds:Q100444166-4444C074-4961-42B3-80B3-22CA76BD133A wds:Q100444166-49F9974B-C679-479C-AA22-BA904057F59E wds:Q100444166-4DFF5CC3-A249-4B24-BF01-F9B91DA8E6BE wds:Q100444166-56B625B3-A84D-4AB5-8027-EFB50703D32A wds:Q100444166-5F8C188F-1AD7-464E-B47F-B7FC1F5A60FE wds:Q100444166-70DAFB4E-6CA7-461D-B3FC-193751462E85 wds:Q100444166-81D5BF85-75CE-4C0A-B21D-1DF4F30025C8 wds:Q100444166-859A59F2-B8D3-4D19-B6F3-C51B5F94AD27 wds:Q100444166-8BA7DE6B-7185-451A-AECF-571CF049C367 wds:Q100444166-90F678E0-0F41-4E18-9FE9-E3B81D02206B wds:Q100444166-95754627-0F62-4EA5-8642-A3AE827609E8 wds:Q100444166-9D5DD5C6-9AC1-4D3D-8356-98A11AAD1A7B wds:Q100444166-A40CA91D-9B77-4200-BCF8-F22ED08C3006 wds:Q100444166-A559790F-8DE4-4913-B8C1-17DE428600D1 wds:Q100444166-AB9D5C60-6062-4EC7-B5A1-FD3CC65464DB wds:Q100444166-AE1E2D29-DE15-4214-8F9A-4C89BC740F32 wds:Q100444166-CE2F0343-A434-4773-867E-33D41B3D0775 wds:Q100444166-D550AE67-BA2C-4AD5-8833-25B4A805D062 wds:Q100444166-E6225D63-00F5-45F5-9F16-CD6230A8AADE wds:Q100444166-ED1A962D-C10D-4680-B274-3524559BFF4E wds:Q100444166-F6C31E6F-FA69-447A-B7D6-37C24C928D7E wds:Q100444166-F73196AC-5CE7-4FFA-B82A-3EDC172CCBE4 wds:Q100444166-FA02F05D-2405-43D7-834B-B244FAD061E2
cites work	Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. ACE2 gene expression is up-regulated in the human failing heart Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure. Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS. Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study ST-Segment Elevation in Patients with Covid-19 - A Case Series Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19 Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
author name string	wds:Q100444166-19F780B7-5663-4BA2-A2FC-99E1F9BD10F7 wds:Q100444166-201BA2EE-2649-48A4-8931-EFDF0F8A81F1 wds:Q100444166-2E5F3208-1688-4635-B7F5-804394D74EC4 wds:Q100444166-59297AEB-DB65-4011-B332-DC056DCE5AA5 wds:Q100444166-77F9A7C7-9738-4BF8-9F6A-A3EFFE486B81 wds:Q100444166-AC394D52-0883-44E0-BBF9-C3AF1CF70072 wds:Q100444166-ED491A62-B2B3-4240-AE1A-AF01F7743072 wds:Q100444166-FE830BF3-393D-4CEB-8631-B8A0C7161DB3
author name string	C Schmid L S Maier M Arzt S Lebek C Birner M Tafelmeier R Messmann Z Provaznik
rdfs:label	ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease (dv) ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease (en) ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease (nl)
skos:prefLabel	ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease (dv) ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease (en) ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease (nl)
name	ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease (dv) ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease (en) ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease (nl)
author	wds:Q100444166-DB36EA3D-D823-4A5C-BC28-80E56BF7A15B
author	Stefan Wagner
title	wds:Q100444166-354CD422-BF93-458F-8C57-5015DD142951
title	ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease (en)
instance of	wds:Q100444166-A8F726A2-8BBD-4F8A-B907-DBE06FEBF0AB
instance of	scholarly article
main subject	wds:Q100444166-3EED7548-98C2-430B-B1F9-CABE0B99C023

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software